Dr. Herbert John Zeh III, MD

Dr. Zeh practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Zeh's NPI, 1306812573, was assigned on February 27, 2006. Dr. Zeh graduated from University of Pittsburgh School of Medicine in 1994. Dr. Zeh holds Texas license R6718.

Dr. Zeh's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Zeh's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Zeh is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Zeh to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zeh practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Zeh's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Zeh is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Zeh's licenses on file in 4 states: Texas, Pennsylvania, Massachusetts and Maryland.

Dmand AI lists abdominal adhesion surgery among the conditions Dr. Zeh treats.

CMS data shows 90 Medicare services from Dr. Zeh across 5 procedure codes in 2024, for 73 Medicare patients. Medicare paid $21,280 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Zeh in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zeh's median patient age at 69, with 46% women.

In 2024, Dr. Zeh wrote 78 Medicare Part D claims for 28 patients. 64% of them were for generic drugs. CMS names the drug for 43 of them, across 2 drugs with 11 or more claims each, at $72,037 in total drug cost. In 2023, CMS named 117 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Zeh for performance year 2024, reported as part of a group. Dr. Zeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zeh as offering telehealth.

Dmand AI links 385 papers to Dr. Zeh, published from 2006 to 2025. 2018 was the busiest year, with 35. The most frequent topics are Pancreatic Neoplasms, Adenocarcinoma and Pancreatectomy. Dr. Zeh has published most often in Ann Surg Oncol. Dr. Zeh's most frequent co-authors are David Lawrence Bartlett, MD, Amer H. Zureikat, MD and Melissa Ellen Hogg, MD.

Dmand AI links Dr. Zeh to 7 clinical trials, 2 of them phase 1 studies. Conditions studied include Pancreatic Neoplasms, Pancreatic Diseases and Gastrointestinal Neoplasms. Amer Zureikat sponsors the most, 2.

CMS Open Payments shows 9 general payments to Dr. Zeh from 4 drug and device companies from 2016 to 2019. Travel and lodging make up the largest share, 51% of the total. Intuitive Surgical, Inc. paid the most, $1,851.

Dmand AI lists 1 award for Dr. Zeh.

Dr. Zeh graduated from University of Pittsburgh School of Medicine in 1994. Dr. Zeh is a member of ACS.

Dr. Zeh is in network with 25 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.